Dr. Cameron Chai

Articles from Cameron

CRAIC Technologies Adds Kinetic Spectroscopy Package to Microspectrophotometer

CRAIC Technologies, a provider of UV-visible-NIR microspectroscopy products, has declared that it has added kinetic spectroscopy features to its 20/20 Perfect Vision UV-visible-NIR microspectrophotometer.

11 Jan 2012

Puralytics’ SolarBag Based on Light-Stimulated Nanotechnology Surpasses EPA Standards

Puralytics, a photochemical water purification product provider using light-stimulated nanotechnology, has declared that its 3 l water purifier, SolarBag is the first-ever non-chemical, non-powered system to satisfy U.S. Environmental Protection Agency’s (EPA) standards for water purification equipment.

10 Jan 2012

Researcher's Theoretical Negative-Index Metamaterial Helps Realize Superlens

Durdu Guney from the Michigan Technological University has developed a model to fabricate a superlens or a perfect lens that is capable of utilizing visible light to view objects measuring 100 nm.

10 Jan 2012

Researchers Demonstrate Magnetism in Graphene

Researchers, Professor Sir Andre Geim and Dr. Irina Grigorieva, from The University of Manchester have demonstrated that graphene can be made to behave like a magnet.

10 Jan 2012

Nanomedicine Company, Blend Therapeutics Announces its Founding Mission

Blend Therapeutics, a biotechnology firm founded by Dr. Omid Farokhzad, Director of Laboratory of Nanomedicine and Biomaterials at Harvard Medical School, and Dr. Stephen Lippard and Dr. Robert Langer, Professors from the Massachusetts Institute of Technology, has declared its founding mission.

10 Jan 2012

Alnylam Submits CTA for Lipid Nanoparticle-Based RNAi TTR, ALN-TTR02

Alnylam Pharmaceuticals, a company specializing in RNAi therapeutics, has announced the submission of a clinical trial application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to start a Phase I clinical study of its RNAi therapeutic targeting transthyretin (TTR) called ALN-TTR02 for treating TTR-mediated amyloidosis (ATTR).

10 Jan 2012

Single Gallium Nitride Nanowires Demonstrate Strong Piezoelectric Behavior

A research team from the Northwestern University has found that one-dimensional materials such as individual gallium nitride nanowires demonstrate powerful piezoelectricity, a three-dimensional phenomenon caused by the application of mechanical stress.

9 Jan 2012

Nanocrystalline Cellulose Presentation by CelluForce at BioPlastek 2012 Forum

CelluForce, a Canada-based joint venture between Domtar and FPInnovations, will deliver a presentation about its novel nano-crystalline cellulose material and its performance-enhancing capabilities at the forthcoming BioPlastek 2012 Forum.

9 Jan 2012

Intertek Cantox Demonstrates Novel Method to Evaluate Nanotoxicology Studies

Intertek Cantox, a company offering regulatory and scientific consulting services, has developed a novel method called the Nano Study Score method to support superior-quality nanotoxicology studies in order to assess the safety of nanomaterial- and nanotechnology-based products.

9 Jan 2012

MonoSol Rx and Nanomedicine Firm Midatech Form Joint Venture Company

Midatech, a nanomedicine company developing MidaForm nanoparticle excipients, and MonoSol Rx, a company developing PharmFilm drug delivery technology, have formed a joint venture company, MidaSol Therapeutics.

9 Jan 2012